McClellan Michael James 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 6, 2019
Insider Transaction Report
Form 4
McClellan Michael James
EVP, Chief Financial Officer
Transactions
- Award
Restricted Share Units
2019-03-04+50,746→ 50,746 total→ Ordinary Shares (50,746 underlying)
Footnotes (3)
- [F1]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F2]Restricted share units were granted on March 4, 2019, with 16,915 vesting on each of March 4, 2021 and March 4, 2022 and 16,916 vesting on March 4, 2023.
- [F3]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.